Within this year, the FDA has applied for an opoglyphron license and aims to launch it next year
Once the IV is in place, most patients find the process relaxing and comfortable
Fronza M, Caetano GF, Leite MN, Bitencourt CS, Paula-Silva FW, Andrade TA, Frade MA, Merfort I, Faccioli LH
The review presents evidence from animal studies demonstrating that amylin reduces food intake and body weight through actions on the area postrema and hypothalamic feeding centers, effects that are preserved in the synthetic analog pramlintide
The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy
Neuroscience Research: Intranasal BPC-157 is studied to characterize potential nose-to-brain transport and CNS biodistribution